{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:07Z","timestamp":1793608027257,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008374","name":"Emory University Center for Aids Research","doi-asserted-by":"publisher","award":["P30 AI050409"],"award-info":[{"award-number":["P30 AI050409"]}],"id":[{"id":"10.13039\/100008374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","award":["CA-943920"],"award-info":[{"award-number":["CA-943920"]}],"id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129174","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:54:57Z","timestamp":1790081697000},"page":"129174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted tuberculosis vaccination strategies in the United States: A modeling study"],"prefix":"10.1016","volume":"92","author":[{"given":"Jessica E.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Lopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel R.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin N.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129174_bb0005","series-title":"Reported tuberculosis in the United States, 2024: national tuberculosis surveillance system","author":"Centers for Disease Control and Prevention","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129174_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwv121","article-title":"A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States","volume":"182","author":"France","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129174_bb0015","series-title":"Screening for latent tuberculosis infection in adults: an evidence review for the U.S. Preventive services task force","author":"Jonas","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129174_bb0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/EDE.0000000000001707","article-title":"Estimated rates of progression to tuberculosis disease for persons infected with mycobacterium tuberculosis in the United States","volume":"35","author":"Ekramnia","year":"2024","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2026.129174_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","article-title":"Latent tuberculosis infection: an overview","volume":"43","author":"Kiazyk","year":"2017","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2026.129174_bb0030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2026.129174_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/14787210.2023.2207820","article-title":"Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies","volume":"21","author":"Graciaa","year":"2023","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.vaccine.2026.129174_bb0040","first-page":"73","article-title":"BCG vaccines: WHO position paper \u2013 February 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.129174_bb0045","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3389\/fmicb.2019.03154","article-title":"Clinical development of new TB vaccines: recent advances and next steps","volume":"10","author":"Hatherill","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.129174_bb0050","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2026.129174_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/joim.13197","article-title":"New tuberculosis vaccines: advances in clinical development and modelling","volume":"288","author":"Weerasuriya","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2026.129174_bb0060","series-title":"Tuberculosis vaccines pipeline report 2024","author":"Frick","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129174_bb0065","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S2214-109X(23)00045-1","article-title":"The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modeling study","volume":"11","author":"Clark","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.129174_bb0070","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.129174_bb0075","doi-asserted-by":"crossref","first-page":"eaax4607","DOI":"10.1126\/scitranslmed.aax4607","article-title":"Potential impact of tuberculosis vaccines in China, South Africa, and India","volume":"12","author":"Harris","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.129174_bb0080","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2468-2667(24)00150-6","article-title":"The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study","volume":"9","author":"Menzies","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2026.129174_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2019.02.020","article-title":"Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings","volume":"469","author":"Renardy","year":"2019","journal-title":"J Theor Biol"},{"key":"10.1016\/j.vaccine.2026.129174_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.129174_bb0095","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","article-title":"Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions","volume":"18","author":"Menzies","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129174_bb0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis","volume":"54","author":"Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129174_bb0105","series-title":"2023 Yearbook of immigration statistics","author":"U.S. Department of Homeland Security","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129174_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.annepidem.2017.05.009","article-title":"Individual- and neighborhood-level contextual factors are associated with mycobacterium tuberculosis transmission: genotypic clustering of cases in Michigan, 2004\u20132012","volume":"27","author":"Noppert","year":"2017","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129174_bb0115","series-title":"Latent TB infection testing and treatment: summary of U.S. recommendations","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"10.1016\/j.vaccine.2026.129174_bb0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"Marino","year":"2008","journal-title":"J Theor Biol"},{"key":"10.1016\/j.vaccine.2026.129174_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis \u2014 United States, 2011\u20132014","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129174_bb0130","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.vaccine.2003.11.052","article-title":"The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over","volume":"22","author":"Kelly","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129174_bb0135","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S2214-109X(18)30452-2","article-title":"Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study","volume":"7","author":"Harris","year":"2019","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:38:25Z","timestamp":1793605105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0264410X26009837"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129174","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted tuberculosis vaccination strategies in the United States: A modeling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129174"}}